Moelis Analyst Ratings
Moelis Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/03/2023 | -30.93% | UBS | $29 → $30 | Maintains | Sell |
07/27/2023 | 28.93% | JP Morgan | $45 → $56 | Maintains | Neutral |
07/12/2023 | -10.21% | Morgan Stanley | $29 → $39 | Maintains | Underweight |
07/12/2023 | -7.91% | Goldman Sachs | $35 → $40 | Maintains | Sell |
06/27/2023 | -33.23% | Morgan Stanley | $29 → $29 | Reiterates | Underweight → Underweight |
04/27/2023 | -14.82% | Keefe, Bruyette & Woods | $40 → $37 | Maintains | Underperform |
04/12/2023 | -33.23% | Morgan Stanley | $30 → $29 | Maintains | Underweight |
03/24/2023 | -17.12% | Goldman Sachs | $40 → $36 | Maintains | Sell |
02/09/2023 | -3.3% | Goldman Sachs | $38 → $42 | Maintains | Sell |
01/11/2023 | -14.82% | Goldman Sachs | $40 → $37 | Downgrades | Neutral → Sell |
01/09/2023 | -30.93% | UBS | $32 → $30 | Maintains | Sell |
11/03/2022 | -7.91% | JP Morgan | $42 → $40 | Maintains | Neutral |
11/03/2022 | -14.82% | Keefe, Bruyette & Woods | $40 → $37 | Downgrades | Market Perform → Underperform |
10/07/2022 | -12.51% | Goldman Sachs | $43 → $38 | Maintains | Neutral |
09/23/2022 | -19.42% | UBS | $43 → $35 | Downgrades | Neutral → Sell |
07/28/2022 | -1% | UBS | $40 → $43 | Maintains | Neutral |
07/18/2022 | -17.12% | Morgan Stanley | $53 → $36 | Downgrades | Equal-Weight → Underweight |
07/11/2022 | -3.3% | Wolfe Research | → $42 | Downgrades | Peer Perform → Underperform |
07/08/2022 | 3.6% | Piper Sandler | $50 → $45 | Maintains | Neutral |
07/06/2022 | -7.91% | UBS | $54 → $40 | Downgrades | Buy → Neutral |
04/28/2022 | 15.11% | Piper Sandler | → $50 | Downgrades | Overweight → Neutral |
04/12/2022 | 3.6% | Goldman Sachs | $50 → $45 | Maintains | Neutral |
04/07/2022 | 19.72% | Piper Sandler | $61 → $52 | Maintains | Overweight |
04/06/2022 | 31.23% | Keefe, Bruyette & Woods | → $57 | Downgrades | Outperform → Market Perform |
03/09/2022 | 40.44% | Piper Sandler | $70 → $61 | Maintains | Overweight |
03/08/2022 | 22.02% | Morgan Stanley | $65 → $53 | Maintains | Equal-Weight |
02/11/2022 | 61.16% | Piper Sandler | $78 → $70 | Upgrades | Neutral → Overweight |
02/10/2022 | 49.65% | Morgan Stanley | $68 → $65 | Maintains | Equal-Weight |
01/06/2022 | 49.65% | Goldman Sachs | $68 → $65 | Upgrades | Sell → Neutral |
01/04/2022 | 68.07% | UBS | $85 → $73 | Maintains | Buy |
12/17/2021 | 77.28% | Keefe, Bruyette & Woods | → $77 | Upgrades | Market Perform → Outperform |
12/08/2021 | 56.56% | Morgan Stanley | $75 → $68 | Maintains | Equal-Weight |
10/11/2021 | 56.56% | Morgan Stanley | $63 → $68 | Maintains | Equal-Weight |
07/22/2021 | 45.04% | Morgan Stanley | $60 → $63 | Maintains | Equal-Weight |
06/17/2021 | 45.04% | Wolfe Research | → $63 | Upgrades | Underperform → Peer Perform |
04/09/2021 | — | JMP Securities | Downgrades | Market Outperform → Market Perform | |
04/07/2021 | 38.14% | Morgan Stanley | $57 → $60 | Maintains | Equal-Weight |
02/11/2021 | 31.23% | Morgan Stanley | $55 → $57 | Maintains | Equal-Weight |
01/11/2021 | 26.63% | Morgan Stanley | $52 → $55 | Maintains | Equal-Weight |
01/07/2021 | 15.11% | JP Morgan | $34 → $50 | Upgrades | Underweight → Neutral |
01/05/2021 | 28.93% | UBS | $40 → $56 | Upgrades | Neutral → Buy |
12/16/2020 | — | Seaport Global | Initiates Coverage On | → Neutral | |
12/14/2020 | 19.72% | Morgan Stanley | $41 → $52 | Maintains | Equal-Weight |
10/27/2020 | -5.61% | Piper Sandler | $37 → $41 | Maintains | Neutral |
10/12/2020 | -5.61% | Morgan Stanley | $29 → $41 | Maintains | Equal-Weight |
10/09/2020 | -3.3% | JMP Securities | $37 → $42 | Maintains | Market Outperform |
10/09/2020 | — | Keefe, Bruyette & Woods | Downgrades | Outperform → Market Perform | |
08/05/2020 | -44.75% | Goldman Sachs | $27 → $24 | Downgrades | Neutral → Sell |
07/30/2020 | -28.63% | Piper Sandler | $32 → $31 | Maintains | Neutral |
07/30/2020 | -33.23% | Morgan Stanley | $31 → $29 | Maintains | Equal-Weight |
07/13/2020 | -37.84% | Goldman Sachs | $34 → $27 | Downgrades | Buy → Neutral |
07/10/2020 | -26.33% | Piper Sandler | $40 → $32 | Downgrades | Overweight → Neutral |
07/07/2020 | -40.14% | JP Morgan | $20 → $26 | Downgrades | Neutral → Underweight |
04/09/2020 | -28.63% | Morgan Stanley | $37 → $31 | Maintains | Equal-Weight |
04/09/2020 | -10.21% | JMP Securities | $45 → $39 | Maintains | Market Outperform |
03/25/2020 | -35.54% | UBS | $33 → $28 | Maintains | Neutral |
02/06/2020 | 12.81% | JP Morgan | $44 → $49 | Maintains | Overweight |
02/06/2020 | -5.61% | Buckingham Research | $39 → $41 | Maintains | Buy |
12/11/2019 | -19.42% | Morgan Stanley | $37 → $35 | Maintains | Equal-Weight |
11/20/2019 | -14.82% | Morgan Stanley | $39 → $37 | Maintains | Equal-Weight |
10/09/2019 | -10.21% | Buckingham Research | $44 → $39 | Maintains | Buy |
10/08/2019 | -10.21% | Morgan Stanley | $41 → $39 | Maintains | Equal-Weight |
07/31/2019 | -10.21% | Keefe, Bruyette & Woods | $42 → $39 | Downgrades | Outperform → Market Perform |
07/11/2019 | 1.3% | Buckingham Research | $53 → $44 | Maintains | Buy |
07/08/2019 | -5.61% | Morgan Stanley | $45 → $41 | Maintains | Equal-Weight |
04/11/2019 | — | B of A Securities | Downgrades | Buy → Underperform | |
04/08/2019 | 15.11% | JMP Securities | $56 → $50 | Maintains | Market Outperform |
01/08/2019 | 5.91% | Morgan Stanley | $59 → $46 | Maintains | Equal-Weight |
11/06/2018 | 22.02% | Goldman Sachs | → $53 | Initiates Coverage On | → Buy |
10/23/2018 | 24.32% | UBS | $59 → $54 | Maintains | Neutral |
10/08/2018 | 35.84% | UBS | $62 → $59 | Maintains | Neutral |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
10/03/2023 | -30.93% | 瑞银集团 | $29→$30 | 维护 | 卖 |
07/27/2023 | 28.93% | 摩根大通 | $45→$56 | 维护 | 中性 |
07/12/2023 | -10.21% | 摩根士丹利 | $29→$39 | 维护 | 体重不足 |
07/12/2023 | -7.91% | 高盛 | $35→$40 | 维护 | 卖 |
2023年6月27日 | -33.23% | 摩根士丹利 | $29→$29 | 重申 | 减码→减码 |
04/27/2023 | -14.82% | Keefe,Bruyette&Wood | $40→$37 | 维护 | 表现不佳 |
04/12/2023 | -33.23% | 摩根士丹利 | $30→$29 | 维护 | 体重不足 |
03/24/2023 | -17.12% | 高盛 | $40→$36 | 维护 | 卖 |
02/09/2023 | -3.3% | 高盛 | $38→$42 | 维护 | 卖 |
2023年1月11日 | -14.82% | 高盛 | $40→$37 | 评级下调 | 中性→销售 |
01/09/2023 | -30.93% | 瑞银集团 | $32→$30 | 维护 | 卖 |
11/03/2022 | -7.91% | 摩根大通 | $42→$40 | 维护 | 中性 |
11/03/2022 | -14.82% | Keefe,Bruyette&Wood | $40→$37 | 评级下调 | 市场表现→表现不佳 |
10/07/2022 | -12.51% | 高盛 | $43→$38 | 维护 | 中性 |
09/23/2022 | -19.42% | 瑞银集团 | $43→$35 | 评级下调 | 中性→销售 |
07/28/2022 | -1% | 瑞银集团 | $40→$43 | 维护 | 中性 |
07/18/2022 | -17.12% | 摩根士丹利 | $53→$36 | 评级下调 | 等重→减码 |
07/11/2022 | -3.3% | 沃尔夫研究 | →$42 | 评级下调 | 同行执行→表现不佳 |
07/08/2022 | 3.6% | 派珀·桑德勒 | $50→$45 | 维护 | 中性 |
07/06/2022 | -7.91% | 瑞银集团 | $54→$40 | 评级下调 | 购买→中性 |
04/28/2022 | 15.11% | 派珀·桑德勒 | →$50 | 评级下调 | 超重→中性 |
04/12/2022 | 3.6% | 高盛 | $50→$45 | 维护 | 中性 |
04/07/2022 | 19.72% | 派珀·桑德勒 | $61→$52 | 维护 | 超重 |
04/06/2022 | 31.23% | Keefe,Bruyette&Wood | →$57 | 评级下调 | 跑赢→市场表现 |
03/09/2022 | 40.44% | 派珀·桑德勒 | $70→$61 | 维护 | 超重 |
03/08/2022 | 22.02% | 摩根士丹利 | $65→$53 | 维护 | 等重 |
02/11/2022 | 61.16% | 派珀·桑德勒 | $78→$70 | 升级 | 中性→超重 |
02/10/2022 | 49.65% | 摩根士丹利 | $68→$65 | 维护 | 等重 |
01/06/2022 | 49.65% | 高盛 | $68→$65 | 升级 | 卖出→中性 |
01/04/2022 | 68.07% | 瑞银集团 | $85→$73 | 维护 | 买 |
2021/12/17 | 77.28% | Keefe,Bruyette&Wood | →$77 | 升级 | 市场表现优于→ |
12/08/2021 | 56.56% | 摩根士丹利 | $75→$68 | 维护 | 等重 |
10/11/2021 | 56.56% | 摩根士丹利 | $63→$68 | 维护 | 等重 |
07/22/2021 | 45.04% | 摩根士丹利 | $60→$63 | 维护 | 等重 |
06/17/2021 | 45.04% | 沃尔夫研究 | →$63 | 升级 | 表现不佳的→对等设备 |
04/09/2021 | - | JMP证券 | 评级下调 | 市场表现优于→市场表现 | |
04/07/2021 | 38.14% | 摩根士丹利 | $57→$60 | 维护 | 等重 |
02/11/2021 | 31.23% | 摩根士丹利 | $55→$57 | 维护 | 等重 |
2021/11/01 | 26.63% | 摩根士丹利 | $52→$55 | 维护 | 等重 |
01/07/2021 | 15.11% | 摩根大通 | $34→$50 | 升级 | 减重→中性 |
01/05/2021 | 28.93% | 瑞银集团 | $40→$56 | 升级 | 中性→购买 |
12/16/2020 | - | 环球海港 | 开始承保 | →中性 | |
12/14/2020 | 19.72% | 摩根士丹利 | $41→$52 | 维护 | 等重 |
10/27/2020 | -5.61% | 派珀·桑德勒 | $37→$41 | 维护 | 中性 |
10/12/2020 | -5.61% | 摩根士丹利 | $29→$41 | 维护 | 等重 |
10/09/2020 | -3.3% | JMP证券 | $37→$42 | 维护 | 市场表现强于大盘 |
10/09/2020 | - | Keefe,Bruyette&Wood | 评级下调 | 跑赢→市场表现 | |
08/05/2020 | -44.75% | 高盛 | $27→$24 | 评级下调 | 中性→销售 |
07/30/2020 | -28.63% | 派珀·桑德勒 | $32→$31 | 维护 | 中性 |
07/30/2020 | -33.23% | 摩根士丹利 | $31→$29 | 维护 | 等重 |
07/13/2020 | -37.84% | 高盛 | $34→$27 | 评级下调 | 购买→中性 |
07/10/2020 | -26.33% | 派珀·桑德勒 | $40→$32 | 评级下调 | 超重→中性 |
07/07/2020 | -40.14% | 摩根大通 | $20→$26 | 评级下调 | 中性→减持 |
04/09/2020 | -28.63% | 摩根士丹利 | $37→$31 | 维护 | 等重 |
04/09/2020 | -10.21% | JMP证券 | $45→$39 | 维护 | 市场表现强于大盘 |
03/25/2020 | -35.54% | 瑞银集团 | $33→$28 | 维护 | 中性 |
02/06/2020 | 12.81% | 摩根大通 | $44→$49 | 维护 | 超重 |
02/06/2020 | -5.61% | 白金汉研究 | $39→$41 | 维护 | 买 |
2019年12月11日 | -19.42% | 摩根士丹利 | $37→$35 | 维护 | 等重 |
2019年11月20日 | -14.82% | 摩根士丹利 | $39→$37 | 维护 | 等重 |
2019年10月09日 | -10.21% | 白金汉研究 | $44→$39 | 维护 | 买 |
2019年10月08日 | -10.21% | 摩根士丹利 | $41→$39 | 维护 | 等重 |
2019年07月31日 | -10.21% | Keefe,Bruyette&Wood | $42→$39 | 评级下调 | 跑赢→市场表现 |
2019年07月11日 | 1.3% | 白金汉研究 | $53→$44 | 维护 | 买 |
2019年07月08日 | -5.61% | 摩根士丹利 | $45→$41 | 维护 | 等重 |
2019年4月11日 | - | B of A证券 | 评级下调 | 购买表现不佳的→ | |
2019年08月04日 | 15.11% | JMP证券 | $56→$50 | 维护 | 市场表现强于大盘 |
2019年08月01日 | 5.91% | 摩根士丹利 | $59→$46 | 维护 | 等重 |
2018/06/11 | 22.02% | 高盛 | →$53 | 开始承保 | →购买 |
2018年10月23日 | 24.32% | 瑞银集团 | $59→$54 | 维护 | 中性 |
10/08/2018 | 35.84% | 瑞银集团 | $62→$59 | 维护 | 中性 |
What is the target price for Moelis (MC)?
莫里斯(Moelis)的目标价是多少?
The latest price target for Moelis (NYSE: MC) was reported by UBS on October 3, 2023. The analyst firm set a price target for $30.00 expecting MC to fall to within 12 months (a possible -30.93% downside). 14 analyst firms have reported ratings in the last year.
瑞银于2023年10月3日报告了Moelis(纽约证券交易所代码:MC)的最新目标价。这家分析公司将目标价定为30.00美元,预计MC将在12个月内下跌(可能下跌30.93%)。过去一年,有14家分析公司公布了评级。
What is the most recent analyst rating for Moelis (MC)?
分析师对莫里斯(Moelis)的最新评级是多少?
The latest analyst rating for Moelis (NYSE: MC) was provided by UBS, and Moelis maintained their sell rating.
对Moelis(纽约证券交易所代码:MC)的最新分析师评级由瑞银提供,Moelis维持其卖出评级。
When is the next analyst rating going to be posted or updated for Moelis (MC)?
莫里斯(Moelis)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Moelis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Moelis was filed on October 3, 2023 so you should expect the next rating to be made available sometime around October 3, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公共财务报表,与Moelis的高管和客户交谈,以及听取收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。Moelis的上一次评级是在2023年10月3日提交的,所以你应该预计下一次评级将在2024年10月3日左右的某个时候提供。
Is the Analyst Rating Moelis (MC) correct?
分析师评级Moelis(MC)正确吗?
While ratings are subjective and will change, the latest Moelis (MC) rating was a maintained with a price target of $29.00 to $30.00. The current price Moelis (MC) is trading at is $43.44, which is out of the analyst's predicted range.
虽然评级是主观的,并将发生变化,但最新的莫里斯(MC)评级维持不变,目标价在29.00美元至30.00美元之间。目前Moelis的交易价格为43.44美元,超出了分析师的预测区间。